Stock 7061 JAPAN HOSPICE HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Japan Hospice Holdings Inc.

Equities

7061

JP3750000006

Healthcare Facilities & Services

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
1,487 JPY -2.04% Intraday chart for Japan Hospice Holdings Inc. -2.68% -34.32%
2023 Japan Hospice Holdings Inc. agreed to acquire Alive Suginami-shoan from Arai Shoten Co., Ltd. for approximately 860 million. CI
2023 Japan Hospice Holdings Inc.(TSE:7061) added to S&P Global BMI Index CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 18,920 13,524 18,405 20,770 18,197 12,239 - -
Enterprise Value (EV) 1 21,032 16,933 24,041 27,349 27,205 12,239 12,239 12,239
P/E ratio 62.2 x 125 x 76.3 x 45.5 x 26.7 x 14.6 x 9.99 x 7.31 x
Yield - - - - - - - -
Capitalization / Revenue 4.51 x 2.75 x 3.06 x 2.63 x 1.84 x 0.96 x 0.75 x 0.61 x
EV / Revenue 4.51 x 2.75 x 3.06 x 2.63 x 1.84 x 0.96 x 0.75 x 0.61 x
EV / EBITDA 30 x 25.6 x 22.3 x 16 x 10.7 x 5.8 x 4.13 x 3.17 x
EV / FCF -49,400,147 x -12,487,811 x - - - - - -
FCF Yield -0% -0% - - - - - -
Price to Book 18.3 x 10.8 x 12.1 x 10.4 x 6.8 x 3.42 x 2.55 x 1.89 x
Nbr of stocks (in thousands) 7,544 7,923 7,971 8,038 8,038 8,231 - -
Reference price 2 2,508 1,707 2,309 2,584 2,264 1,487 1,487 1,487
Announcement Date 2/13/20 2/12/21 2/10/22 2/10/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 4,193 4,916 6,019 7,894 9,871 12,800 16,400 20,000
EBITDA 1 630.6 528 826.8 1,296 1,695 2,110 2,960 3,860
EBIT 1 501 358 598 959 1,283 1,550 2,200 2,900
Operating Margin 11.95% 7.28% 9.94% 12.15% 13% 12.11% 13.41% 14.5%
Earnings before Tax (EBT) 1 387 206 417 784 1,028 1,300 1,900 2,600
Net income 1 297 107 240 454 681 820 1,200 1,640
Net margin 7.08% 2.18% 3.99% 5.75% 6.9% 6.41% 7.32% 8.2%
EPS 2 40.30 13.61 30.28 56.73 84.81 101.7 148.9 203.5
Free Cash Flow -383 -1,083 - - - - - -
FCF margin -9.13% -22.03% - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/13/20 2/12/21 2/10/22 2/10/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 2,286 2,630 2,820 1,618 3,199 1,619 1,890 3,509 2,124 2,261 4,385 2,245 2,404 4,649 2,572 2,650 2,725 2,989 5,748 3,359 3,691
EBITDA - - - - - - - - - - - - - - - - - - - - -
EBIT 1 100 258 190 198 408 96 210 306 285 368 653 321 356 677 394 212 268 330 560 470 520
Operating Margin 4.37% 9.81% 6.74% 12.24% 12.75% 5.93% 11.11% 8.72% 13.42% 16.28% 14.89% 14.3% 14.81% 14.56% 15.32% 8% 9.83% 11.04% 9.74% 13.99% 14.09%
Earnings before Tax (EBT) 1 30 176 122 137 295 116 137 253 211 320 531 264 273 537 301 190 246 280 460 420 420
Net income 1 6 101 66 76 174 71 69 140 120 194 314 164 191 355 203 123 152 176 289 264 265
Net margin 0.26% 3.84% 2.34% 4.7% 5.44% 4.39% 3.65% 3.99% 5.65% 8.58% 7.16% 7.31% 7.95% 7.64% 7.89% 4.64% 5.58% 5.89% 5.03% 7.86% 7.18%
EPS 0.7900 - 8.360 - - 8.890 - 17.50 14.98 - - 20.47 - 44.21 25.32 - 18.71 - - - -
Dividend per Share - - - - - - - - - - - - - - - - - - - - -
Announcement Date 8/14/20 2/12/21 8/13/21 2/10/22 2/10/22 5/13/22 8/12/22 8/12/22 11/14/22 2/10/23 2/10/23 5/12/23 8/10/23 8/10/23 11/10/23 2/13/24 5/10/24 - - - -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 2,112 3,409 5,636 6,579 9,008 - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) 3.349 x 6.456 x 6.817 x 5.076 x 5.313 x - - -
Free Cash Flow -383 -1,083 - - - - - -
ROE (net income / shareholders' equity) 42.5% 9.3% 17.3% 25.8% 29.1% 26.5% 29.2% 29.7%
ROA (Net income/ Total Assets) 9.65% 3.75% 5.4% - 7.7% 7.9% 9.9% 11.6%
Assets 1 3,078 2,853 4,444 - 8,844 10,380 12,121 14,138
Book Value Per Share 2 137.0 158.0 191.0 249.0 333.0 435.0 584.0 787.0
Cash Flow per Share 50.10 28.00 51.80 91.10 128.0 - - -
Capex 1 76.1 1,319 1,913 2,131 1,982 1,500 1,500 1,500
Capex / Sales 1.82% 26.83% 31.78% 27% 20.08% 11.72% 9.15% 7.5%
Announcement Date 2/13/20 2/12/21 2/10/22 2/10/23 2/13/24 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Japan Hospice Holdings Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
JAPAN HOSPICE HOLDINGS INC. Stock Japan Hospice Holdings Inc.
-34.32% 80.47M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+19.28% 84.52B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-26.95% 72.21B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+4.65% 27.74B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-7.35% 17.97B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.46% 17.46B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+4.69% 15.82B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+8.14% 13.55B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+6.59% 13.31B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+70.00% 12.5B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. 7061 Stock
  4. Financials Japan Hospice Holdings Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW